Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,820 | -3,220 | N/A | -5,900 | 10 |
| Depreciation Amortization | 820 | 3,180 | N/A | 1,530 | 700 |
| Other Working Capital | -1,490 | -8,690 | N/A | -2,740 | -440 |
| Other Operating Activity | 1,900 | -14,400 | 0 | -5,890 | -4,850 |
| Operating Cash Flow | $-7,590 | $-23,130 | $N/A | $-13,000 | $-4,580 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -420 | -1,000 | N/A | -440 | -260 |
| Net Acquisitions | 0 | 0 | N/A | 1,770 | 0 |
| Other Investing Activity | 5,010 | 16,440 | 0 | 4,940 | 4,900 |
| Investing Cash Flow | $4,590 | $15,440 | $N/A | $6,270 | $4,640 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 14,320 | 6,950 | 0 | 8,140 | 740 |
| Financing Cash Flow | $14,320 | $6,950 | $N/A | $8,140 | $740 |
| Exchange Rate Effect | -50 | 20 | N/A | -100 | 90 |
| Beginning Cash Position | 2,740 | 3,450 | N/A | 3,450 | 3,450 |
| End Cash Position | 14,010 | 2,740 | N/A | 4,750 | 4,340 |
| Net Cash Flow | $11,260 | $-710 | $N/A | $1,290 | $890 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,590 | -23,130 | N/A | -13,000 | -4,580 |
| Free Cash Flow | -7,590 | -23,130 | 0 | -13,000 | -4,580 |